Family · Pharmaceutical analytical standards
Valdecoxib
A selective COX-2 inhibitor among the non-steroidal anti-inflammatory drugs, approved in the United States in 2001 for osteoarthritis, rheumatoid arthritis and menstrual pain; it was withdrawn from the market in 2005. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It lives on through parecoxib, a water-soluble injectable prodrug approved in Europe in 2002 for post-operative pain, which the body converts into valdecoxib itself.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
